Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 237-926-1 | CAS number: 14073-97-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vivo
Description of key information
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Valid and conclusive guideline study under GLP
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- The relative humidity in the animal rooms ranged between 30-114 % instead of 30 and 70 %
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories GmbH, 33178 Borchen, Germany
- Age at study initiation: 8 - 10 weeks
- Weight at study initiation: males mean value 35.7 g, females mean value 31.4 g
- Assigned to test groups randomly: yes
- Fasting period before study: no data
- Housing: single
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: minimum 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 30 - 114
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: no data
- Concentration of test material in vehicle: 50, 100, 200 mg/mL
- Amount of vehicle (if gavage or dermal): 10 mL/kg
- Lot/batch no. (if required): no data
- Purity: no data - Details on exposure:
- not applicable (gavage)
- Duration of treatment / exposure:
- once
- Frequency of treatment:
- once
- Post exposure period:
- 24 and 48 hours
- Remarks:
- Doses / Concentrations:
500, 1000, 2000 mg/kg bw
Basis:
actual ingested
nominal dose - No. of animals per sex per dose:
- 12
- Control animals:
- yes
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): no data
- Route of administration: oral (gavage)
- Doses / concentrations: 40 mg/kg bw - Tissues and cell types examined:
- bonne marrow, polychromatic erythrocytes (PCE)
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: the highest dose was the maximum tolerated dose of 2000 mg/kg. A total tree adequately spaced dose levels spaced by a factor of 2 were chosen.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields): treatment once and sampling time 24 and 48 hours post-dose.
DETAILS OF SLIDE PREPARATION: the marrow was flushed out with foetal calf serum using a syringe. The cell suspension was centrifuged at 390 x g for 10 minutesand the supernatant was discarded. A small drop of the re-suspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grünwald (Merk, 64293 Darmstadt, Germany)/Giemsa (Merk, 64293 Darmstadt, Germany). Cover slips were mounted with EUKITT (Kindler, 79110 Freiburg, Germany). At least one slide was made from bone marrow sample.
METHOD OF ANALYSIS: NIKON microscopes with 100x oil immersion objectives. At least 2000 polychromatic erythrocytes (PCE) were analysed per animal for micronuclei. To describe a cytotoxic effect the ratio between polychromatic and normochromatic erythrocytes was determined in the same sample and expressed in polychromatic erythrocytes per 2000 erythrocytes. - Evaluation criteria:
- The study was considered valid as the following criteria are met:
-the negative and positive controls are in the range of historical control data.
-at least 5 animals per group and sex can be evaluated.
-PCE to erythrocyte ratio should not be less than 20 % of the negative control. - Statistics:
- A test item is classified as mutagenic if it induces either a dose-related increase or a clear increase in the number of micronucleated polychromatic erytrocytes in a single dose group. A test item that fails to produce a biological relevant increase in the number of micronucleated polychromatic erythrocytes is considered non-mutatgenic in this system. Nonparametric Mann-Whitney test.
- Conclusions:
- Interpretation of results (migrated information): negative
L-menthone is considered to be non-mutagenic in this micronucleous assay. - Executive summary:
The study was performed to investigate the potential of L-menthone to induce micronuclei in polychromatic erythrocytes (PCE) in the bone marrow of the mouse. The test item was formulated in corn oil, which was also used as vehicle control. The volume administered orally was 10 mL/kg bw. 24 h and 48 h after a single administration of the test item the bone marrow cells were collected for micronuclei analysis. Ten animals (5 males, 5 females) per test group were evaluated for the occurence of micronuclei. At least 2000 PCEs per animal were scored for micronuclei. To describe a cytotoxic effect due to the treatment with the test item the ratio between polychromatic and normochromatic erytrocytes was determined in the same sample and reported as the number of PCEs per 2000 erythrocytes. The following dose levels of the test item were investigated:
24 h preparation interval: 500, 1000 and 2000 mg/kg bw
48 h preparation interval: 2000 mg/kg bw
The highest dose (2000 mg/kg; maximum guideline-recommended dose) was estimated by a pre-experiment to be suitable. In the main study 1 male died after treatment with this dose. After treatment with the test item the number of PCEs was not substantially decreased as compared to the mean value of PCEs of the vehicle control thus indicating that L-menthone did not exert any cytotoxic effects in the bone marrow.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
- in vitro:
The Ames test (Sokolowski 2012) was performed to investigate the potential of Menthone-L/Isomenthone-D to induce gene mutations in the plate incorporation test (Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100, and the Escherichia coli strain WP2uvrA: 3-5000 µg/plate) and the preincubation test (TA1535, TA1537, TA100: 1-2500 µg/plate, TA98, WPuvrA: 3-5000 µg/plate). The assay was performed in two independent experiments, both with and without liver microsomal activation. No substantial increase in revertant colony members of any of the five tester strains was observed following treatment with Menthone-L/Isomenthone-D at any dose level, neither in the presence nor absence of metabolic activation (S9mix).
The HPRT test (Wollny, 2013) was performed in order to investigate the mutagenic potential in mammalian Chinese hamster V79 cells. The assay was performed in two independent experiments with and without liver microsomal activation. The test item was shown to be non-mutagenic to V79 cells at the HPRT locus under the conditions of the test.
-in vivo:
In the study (Honarvar 2009) the potential of L-menthone to induce micronuclei in polychromatic erytrocytes (PCE) in the bone marrow of the mouse was investigated. After single oral administration of 10 mL/kg bw of test item, the bone marrow cells were collected at 24 and 48 h for micronuclei analysis. After treatment with the test item the number of PCEs was not substantially decreased as compared to the mean value of PECs of the vehicle control thus indicating that L-menthone did not exert any cytotoxic effects in the bone marrow.
Justification for selection of genetic toxicity endpoint
in vivo GLP study according to OECD TG 474
Justification for classification or non-classification
Based on the above stated assessment of the genotoxic potential of L-menthan-3-one the substance is considered to be non-genotoxic and classification according to Council Directive 2001/59/EC (28th ATP of Directive 67/548/EEC) and CLP (Regulation (EC) No 1272/2008 of the European Parliament and of the Council) as implementation of UN-GHS in the EU is not proposed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.